Skip to content
The Great News – Lifestyle
Home
Sample Page
Author:
AnnJi Pharmaceutical Co., Ltd.
AnnJi Pharmaceutical Advances AJ201 into Pivotal Phase 3 ROMA-KD Trial for Spinal and Bulbar Muscular Atrophy (SBMA)
October 5, 2026